Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLoose stool is one of the most commonly reported side effects of semaglutide (Wegovy). It tends to arrive in the first few weeks of treatment or after a dose increase, usually settles on its own within days, and is rarely a reason to stop — but it can be uncomfortable enough that you deserve a clear picture of what's happening and why. These are prescription-only medicines; a prescriber decides whether they're right for you, and any symptoms that worry you should be discussed with your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is one of the most common scenarios our prescribers hear about: someone starts semaglutide feeling motivated, and within the first fortnight their digestive system objects. Loose stools, more frequent trips to the bathroom, a general sense that things are moving faster than usual — it's unsettling, but it fits a well-understood pattern.
Semaglutide works partly by slowing gastric emptying: food sits in the stomach longer before moving into the small intestine. That delay changes the rhythm of the whole digestive tract, and for many people the lower gut responds with looser stools or mild diarrhoea, particularly early on. The NHS semaglutide medicines page lists diarrhoea and loose stools among the common side effects, affecting more than one in ten people taking the medicine.
The timing matters. Symptoms tend to cluster around two points: the very start of treatment, and each upward dose step. Between dose increases, the gut usually adapts. Most people find the worst of it passes within a week or two, not because the medicine stops working, but because the body recalibrates. Keeping a rough mental note of when symptoms started relative to your last dose change is useful information if you speak to your prescriber.
One practical detail: if you keep your Wegovy pen in the fridge door (the recommended cool storage spot between uses), making that part of a check-in routine (pen in hand, reflect on how the past week felt) can help you notice patterns early rather than pushing through in silence. It's also worth knowing that digestive changes aren't the only physical shift people notice, and if you're curious about how Wegovy affects skin as weight comes off, that's something worth reading about early in your treatment journey.
Most loose stools on semaglutide are self-limiting and mild. That said, there are signals worth knowing before you need them.
The adjustment zone (the first one to two weeks at a new dose) is when symptoms are most forgivable. Eating smaller portions, choosing lower-fat foods temporarily, and drinking enough water across the day are the practical levers most people find helpful. Fatty or heavily spiced meals can amplify gut-related side effects, so a short period of blander eating is a reasonable response, not a permanent sacrifice.
Dehydration is the main risk from prolonged loose stools. If you're losing fluid consistently over more than a day or two, replace it deliberately: plain water, diluted squash, or an oral rehydration drink if things are severe. Kidney function can be affected by significant dehydration, which is why the guidance asks you to seek medical advice if GI symptoms are persistent or intense.
There are symptoms that move beyond normal adjustment. Blood in the stool (whether bright red or darker) is not a typical side effect of semaglutide and should be assessed promptly; our guide to semaglutide and blood in the stool covers this in detail. Severe pain in the abdomen, especially pain that radiates towards the back, needs urgent medical attention given the known association between GLP-1 medicines and acute pancreatitis, highlighted in a January 2026 MHRA Drug Safety Update. Dark or tar-like stools are a separate concern covered on the Wegovy dark stool page.
Pain on the left side of the abdomen that accompanies loose stools can occasionally reflect different processes; if that's your experience, the left-side pain and Wegovy page gives more context.
There's no single fix, but there are sensible adjustments that sit comfortably alongside semaglutide treatment. Smaller, more frequent meals reduce the load on a gut that's already working differently. Cutting back on high-fat foods (not permanently, just during the adjustment window) tends to reduce both the frequency and urgency of loose stools. Soluble fibre (oats, cooked vegetables, pulp-free fruit) can help firm up stool consistency without the bloating that insoluble fibre sometimes causes.
Avoid the temptation to stop eating to stop symptoms. Under-eating while on semaglutide risks inadequate protein and micronutrient intake, which matters more here than on an ordinary diet. If you're struggling to eat enough, your prescriber is the right person to talk to, not a symptom to quietly endure.
For broader context on how semaglutide works and what to expect across the treatment period, the semaglutide overview and the Wegovy treatment page are good starting points. If you're weighing up your options and want to understand what private treatment involves, information on weight-loss treatment routes sets out the landscape clearly.
Contact your prescriber or GP if loose stools persist beyond two weeks on a stable dose, if you're unable to stay hydrated, or if you notice any of the warning signs described above. Urgently seek care for severe abdominal pain, signs of dehydration (dizziness, very dark urine, confusion), allergic reactions, or any rectal bleeding.
The MHRA's Yellow Card scheme allows anyone to report suspected side effects from medicines, including semaglutide. Reports from real-world patients help regulators monitor safety signals that weren't fully visible in clinical trials, it's a simple online form and takes a few minutes.
If you're thinking about starting treatment and want your suitability assessed by a clinician, you can check your eligibility with a free consultation at any point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.